Trial of Psilocybin vs Escitalopram for Depression
July 27, 2021 DOI: 10.64239/pi-qt2903
Summary
Escitalopram was found to be equivalent in effectiveness to a placebo for treating mood disorders, indicating that it does not offer a significant advantage over the placebo. This finding raises questions about the motivations behind pharmaceutical company funding in such studies.
Study at a glance
| Key finding | Escitalopram was not better than a placebo for treating mood disorders. |
|---|
Abstract
A mood disorder study published in the New England Journal of Medicine is a bullet unto itself. Use of escitalopram, not a placebo, for the comparison group—another rarity! And the results? Well, not better, but equivalent. Here comes big pharmaceutical company money.